| abstract |
The present invention relates to a compound of formula (I) below: or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in all proportions, wherein: - X represents a CH or C = O, - X group represents a linear hydrocarbon chain, saturated or unsaturated, containing from 1 to 24, preferably from 8 to 22 carbon atoms, - R represents a hydrogen atom or an OH or (C -C) alkoxy group, such as methoxy, and R represents a CH or CH OR group, with R representing a hydrogen atom or a (C -C) alkyl, CO- (C -C) alkyl or NH- (C -C) alkyl group, as well as its use; as a medicament, particularly for the treatment of neurodegenerative diseases, and its method of preparation. |